{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:09:36Z","timestamp":1787004576448,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,28]],"date-time":"2015-12-28T00:00:00Z","timestamp":1451260800000},"content-version":"vor","delay-in-days":5474,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2001]]},"DOI":"10.1046\/j.1469-0691.2001.00058.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:25:53Z","timestamp":1047367553000},"page":"47-52","source":"Crossref","is-referenced-by-count":34,"special_numbering":"S4","title":["Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy"],"prefix":"10.1016","volume":"7","author":[{"given":"N.M.A.","family":"Blijlevens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.E.","family":"de Pauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1046\/j.1469-0691.2001.00058.x_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Int Med"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/infdis\/144.1.10","article-title":"Patterns of oropharyngeal ans fecal flora in patients with adult leukemia","volume":"144","author":"Fainstein","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1086\/598620","article-title":"Changing epidemiology of infections in patients with neutropenia and cancer; emphasis on Gram-positive and resistant bacteria","volume":"29","author":"Zinner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/jac\/44.5.587","article-title":"The prophylaxis of bacterial infections in neutropenic patients","volume":"44","author":"Kerr","year":"1999","journal-title":"J Antimicrobial Chemotherapy"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM197105132841904","article-title":"Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia","volume":"284","author":"Schimpff","year":"1971","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib6","doi-asserted-by":"crossref","first-page":"834","DOI":"10.7326\/0003-4819-120-10-199405150-00004","article-title":"Ceftazidime compared with piperacillin and trobramycin for the empirical treatment of fever in neutropenic patients with cancer \u2013 a multicenter randomized trial","volume":"120","author":"De Pauw","year":"1994","journal-title":"Ann Intern Med"},{"issue":"Suppl. 740","key":"10.1046\/j.1469-0691.2001.00058.x_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/joim.1997.242.s740.69","article-title":"Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient","volume":"242","author":"De Pauw","year":"1997","journal-title":"J Intern Med"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1128\/AAC.36.5.1062","article-title":"Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime \u2013 a randomized prospective study","volume":"36","author":"Ramphal","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/AAC.35.4.672","article-title":"Ceftazidime as monotherapy or combined with teicoplanin for initial empirical treatment of presumed bacteremia in febrile granulocytopenic patients","volume":"35","author":"Novakova","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/163.5.951","article-title":"Vancomycin added to empirical combination therapy for fever in granulocytopenic cancer patients","volume":"163","author":"The EORTC International Antimicrobial Therapy Cooperative Group and National Cancer Institute of Canada","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/sj.bmt.1701614","article-title":"Early infections in patients undergoing bone marrow or blood stem cell transplantation \u2013 a 7 year single centre investigation of 409 cases","volume":"23","author":"Kruger","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/jac\/45.6.843","article-title":"A prospective, randomized, double-blinded, placebo-controlled trial of empirical teicoplanin in febrile neutropenia with persistent fever after imipenem monotherapy","volume":"45","author":"Erjavec","year":"2000","journal-title":"J Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1046\/j.1469-0691.2001.00058.x_bib13","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0959-8049(96)00050-0","article-title":"Early identification of neutropenic patients at risk of Gram-positive bacteraemia and the impact of empirical administration of vancomycin","volume":"32A","author":"Dompeling","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(96)09229-X","article-title":"Excretion ciprofloxacin in sweat and multiresistant staphylococcus epidermidis","volume":"349","author":"Hoiby","year":"1997","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib15","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.44.10.2855-2857.2000","article-title":"Excretion of beta-lactam antibiotics in sweat \u2013 a neglected mechanism for development of antibiotic resistance?","volume":"44","author":"Hoiby","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib16","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/clinids\/20.5.1169","article-title":"Bacteremia due to viridans streptococci that are highly resistant to penicillin: increase among neutropenic patients with cancer","volume":"20","author":"Carratala","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/sj.bmt.1701140","article-title":"Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation","volume":"21","author":"Bilgrami","year":"1998","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1046\/j.1469-0691.2001.00058.x_bib18","first-page":"409","article-title":"A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients","volume":"9","author":"Donnelly","year":"1992","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"10.1046\/j.1469-0691.2001.00058.x_bib19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","article-title":"The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies","volume":"82","author":"Ruescher","year":"1998","journal-title":"Cancer"},{"issue":"2","key":"10.1046\/j.1469-0691.2001.00058.x_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/clinids\/20.2.469","article-title":"Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis","volume":"20","author":"Donnelly","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib21","first-page":"565","article-title":"Cytosine arabinoside as a major risk factor for streptococcus viridans septicemia following bone marrow transplantation: a 5 year prospective study","volume":"16","author":"Engelhard","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/clinids\/18.1.25","article-title":"Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors","volume":"18","author":"Bochud","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"6 Suppl. 8","key":"10.1046\/j.1469-0691.2001.00058.x_bib23","first-page":"47","article-title":"Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent","volume":"20","author":"Muus","year":"1993","journal-title":"Semin Oncol"},{"issue":"6","key":"10.1046\/j.1469-0691.2001.00058.x_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0964-1955(97)00032-8","article-title":"Oral sources of septicaemia in patients with malignancies","volume":"33","author":"Meurman","year":"1997","journal-title":"Oral Oncol"},{"issue":"6","key":"10.1046\/j.1469-0691.2001.00058.x_bib25","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","article-title":"Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors","volume":"14","author":"Elting","year":"1992","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1046\/j.1469-0691.2001.00058.x_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/520134","article-title":"Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis","volume":"29","author":"Hall","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1046\/j.1469-0691.2001.00058.x_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0163-4453(97)91545-0","article-title":"Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation","volume":"35","author":"Lucas","year":"1997","journal-title":"J Infect"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib28","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/317460","article-title":"Serious complications of bacteremia caused by viridans streptococci in neutropenic patients with cancer","volume":"31","author":"Marron","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1046\/j.1469-0691.2001.00058.x_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01698484","article-title":"Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine","volume":"69","author":"Dompeling","year":"1994","journal-title":"Ann Hematol"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1086\/514550","article-title":"Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials","volume":"25","author":"Elting","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/AAC.38.3.465","article-title":"Randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis","volume":"30","author":"Kern","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-97-4-503","article-title":"Staphylococcus epidermidis. an increasing cause of infection in patients with granulocytopenia","volume":"97","author":"Wade","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01695660","article-title":"Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution","volume":"15","author":"Gonzalez-Barca","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib34","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2307\/30147066","article-title":"Molecular epidemiology of coagulase-negative staphylococci isolated from immunocompromised patients","volume":"13","author":"Herwaldt","year":"1992","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1046\/j.1469-0691.2001.00058.x_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1099\/0022-1317-49-4-367","article-title":"Origins of Staphylococcus epidermidis and Streptococcus oralis causing bacteraemia in a bone marrow transplant patient","volume":"49","author":"Kennedy","year":"2000","journal-title":"J Med Microbiol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15301154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X15301154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T22:13:59Z","timestamp":1580940839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X15301154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001]]},"references-count":35,"alternative-id":["S1198743X15301154"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2001.00058.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2001]]}}}